• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Science translational medicine

    Science translational medicine

    JournalISSN 1946-6234eISSN 1946-6242中科院 医学 1区

    年发文量

    研究主题

    论文(7421)

    排序
    1NewOsimertinib, Platinum, and Etoposide for Patients with Metastatic EGFR / TP53 / RB1 -Mutant Lung Cancers at Risk for Histological Transformation
    Lena Morrill Gavarró,Monica F. Chen,Àlvaro Quintanal-Villalonga, Yufei Deng, Liancheng Lu, Britney Forsyth, Sahil Sahni, Eric G. Sun,Swanand Rakhade, Rania Gaber Mohamed Aly, Meng Wang, Amin H. Sabet,

    Although EGFR inhibitors are highly effective for treating EGFR- mutant lung adenocarcinomas ( EGFR + LUADs), resistance inevitably emerges, with histologic transformation to small cell lung cancer (SCLC) representing a particularly aggressive mechanism. Our prospective trial enrolled patients with EGFR + LUAD at high risk of transformation ( TP53 / RB1 -deficient) and treated them with first-line osimertinib combined with platinum and etoposide. Despite the addition of SCLC-directed chemotherapy, nearly half of patients (5 of 11) underwent SCLC transformation, with median progression-free survival of 11 months and overall survival of 33 months. Genomic and single-cell transcriptomic profiling of patient samples revealed clinical and subclinical plasticity associated with TP53 / RB1 comutations, including histological transformation to SCLC, as well as mesenchymal and squamous histologies. These changes in plasticity were linked to progressive disruption of the RB pathway, leading to altered chromatin accessibility and induction of neuronal differentiation and epithelial-to-mesenchymal transition transcriptional programs, further intensified by osimertinib treatment. These findings provide insights into the role of plasticity in mediating drug tolerance.

    2026
    引用
    AI阅读
    加入学术空间
    2NewHuman Antibody Combinations Determined by Epitope Mapping of Orthopoxvirus A33/A35 Confer Therapeutic Protection in Mice
    Anqi Xia,Qiwei Jiang, Xiaojie Wang, Jie Liu, Jiannan Chen, Haozhe Zhao, Siyuan Sun,Wei Wu,Weiyu Jiang,Song Xue,Yi-ou Sha, Yingying Song,

    Human infections with mpox virus (MPXV) since 2022 have resulted in more than 188,000 cases reported globally as of June 2026, highlighting the urgent need for effective therapeutics. Here, we recruited smallpox vaccinees and donors with incidental vaccinia virus (VACV) exposure and isolated a panel of human anti-A33/A35 monoclonal antibodies (mAbs) from the latter using recombinant MPXV A35 as a cross-reactive bait. These mAbs recognized four distinct nonoverlapping epitopes (epitopes 1 to 4) and one composite epitope (epitope 3 + 4) on MPXV A35 and exhibited cross-reactivity against multiple orthopoxviruses (OPXVs). Cryo–electron microscopy structural analysis revealed that the high-affinity epitope 3 + 4 mAb HD15 engages an epitope at the A35 dimer interface that is conserved across OPXVs. Combinations of mAbs targeting nonoverlapping epitopes mediated synergistic, Fc-dependent neutralization in vitro; conferred therapeutic protection against lethal VACV challenge; and reduced viral burden and disease severity after MPXV challenge in mice. Together, these findings establish a single-antigen, multiepitope strategy for the development of broadly protective therapeutics against OPXVs.

    2026
    引用
    AI阅读
    加入学术空间
    3NewDual Inhibition of TNF-α and IL-1β Signaling Through BIG2 Ameliorates Osteoarthritis in Mouse and Primate Models
    Wenyu Fu,Ronghan Liu,Jin Wo, Xinhui Liu, Shuya Wang,Wenhao Song, H.-Y. Zhu, Yazhou Cui,Yuehong Chen, Chao Wang,Lei Zhang, Ran M. Schwarzkopf,

    Osteoarthritis (OA), a leading cause of disability, is characterized by chronic low-grade inflammation and metabolic dysregulation in chondrocytes. TNF-α and IL-1β are key inflammatory drivers in OA pathogenesis, but clinical trials targeting them individually have been unsuccessful, highlighting the potential need for dual-targeting strategies. By screening a US Food and Drug Administration–approved drug library, we identified dabigatran, a thrombin inhibitor, as a potent dual suppressor of TNF-α and IL-1β signaling that restored chondrocyte metabolism. In preclinical OA models, including both mice and cynomolgus macaques, dabigatran attenuated cartilage degeneration, alleviated pain, and improved joint function. To elucidate the molecular mechanisms, we performed biochemical copurification coupled with mass spectrometry, identifying brefeldin A–inhibited guanine nucleotide–exchange protein 2 (BIG2) as a previously unknown dabigatran-binding target. Mechanistically, dabigatran binds to BIG2, promoting BIG2-dependent TNFR1 release to dampen TNF-α signaling while enhancing BIG2-mediated IL-1R1 degradation through the autophagy-lysosome pathway to limit IL-1β effects. These findings establish BIG2-mediated receptor trafficking and membrane dynamics as a regulatory node that concurrently inhibits TNF-α and IL-1β signaling, suggesting this pathway as a potential therapeutic strategy for OA.

    2026
    引用
    AI阅读
    加入学术空间
    4NewAlbumin-bound Paclitaxel–induced Stromal Reprogramming Drives Resistance to Neoadjuvant Chemotherapy in Patients with Pancreatic Cancer
    Haorui Li, Xi Ma,Xupeng Hou,Xugang Sun, Xiang He, Kejia Liu, Henan Cao, Libo Wang, Yibo Dou, Jie Yu,Bin Wang,Tianxing Zhou,

    Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy for which neoadjuvant chemotherapy with albumin-bound paclitaxel combined with gemcitabine (AG) is a standard first-line approach for borderline resectable and locally advanced disease. However, secondary resistance to this regimen is common, and its underlying mechanisms remain poorly defined. In this study, we investigated how neoadjuvant AG therapy shapes the tumor stroma in PDAC. Single-cell transcriptomics of patient tumors revealed that AG treatment induces a phenotypic switch of cancer-associated fibroblasts (CAFs) from myofibroblastic (myCAF) to inflammatory (iCAF) states and identified a previously unrecognized TMEM100 + CAF subset enriched in nonresponders. Mechanistic studies showed that albumin-bound paclitaxel activates IL-2–STAT5 signaling to drive TMEM100 expression and that TMEM100 + CAFs promote chemoresistance through paracrine secretion of amphiregulin (AREG) and activation of tumor EGFR signaling. Genetic ablation of TMEM100 + CAFs in mouse models reversed CAF switching and enhanced the antitumor efficacy of AG therapy. These findings map chemotherapy-induced CAF plasticity, reveal a TMEM100-AREG axis of resistance, and highlight TMEM100 + CAFs as a promising target to sensitize PDAC to neoadjuvant treatment.

    2026
    引用
    AI阅读
    加入学术空间
    5NewSleep-like Slow Waves During Wakefulness Are Associated with Hallucinations and Poorer Cognition in Parkinson’s Disease
    Fosco Bernasconi,Thomas Andrillon, Juan Carlos Farah,Isabelle Arnulf,Sophie Schwartz,Jevita Potheegadoo,Saül Martínez‐Horta,Javier Pagonabarraga,Jaime Kulisevsky,Olaf Blanke

    Slow waves during sleep are fundamental for neural homeostasis, metabolic regulation, and waste clearance and are known to be altered in neurodegenerative diseases. Sleep-like slow waves (SLSWs) have been observed in awake, healthy individuals, where they are linked to fluctuations in vigilance and mind-wandering. Whether SLSWs are altered in Parkinson’s disease (PD), and whether such alterations contribute to psychiatric or cognitive complications, remains unknown. In a cohort of 84 nondemented patients with PD and 30 healthy older adults, we found that SLSWs occurred more frequently in patients with PD. Hallucinatory traits in patients with PD were associated with higher SLSW amplitude, especially over frontocentral regions. Moreover, more prominent SLSWs were associated with poorer cognitive functions. We conclude that, whereas slow waves during sleep have positive physiological functions, exacerbated diurnal SLSWs may reflect responses related to PD neuropathology, at the cost of hallucinations and reduced cognitive function.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 7421 篇论文

    高被引作者

    作者引用发文
    Carl H. June1488714
    Bruce L. Levine135428
    Luis Diaz Jr.1095812
    Bert Vogelstein1070919
    Kenneth W. Kinzler1070918
    Nickolas Papadopoulos981914
    Stephan A. Grupp88193
    David L. Porter85112
    Adam Bagg85112
    Isaac Kinde81236

    高产作者

    作者引用发文
    Rino Rappuoli201028
    Samir B. Damani15727
    John mascola258527
    Bettegowda Chetan625024
    David M. Holtzman714124
    Robert S. Langer491123
    Dan H. Barouch110622
    George A. Mashour2520
    Joshi Alumkal6920
    Peter D. Kwong116820

    相关期刊

    Immunity
    Gene expression
    The Journal of Clinical Investigation
    Journal of Experimental Medicine
    Cell Reports
    JCI insight
    Signal transduction and targeted therapy
    Journal of Immunology
    EBioMedicine
    Cell Reports Medicine